Acceptable Use Policy
This policy applies to all visitors, business users and authorised users of the Website and any Company-controlled enquiry facility. Separate ordering, stock / sales and supplier portals may have additional acceptable-use terms.
1 Permitted use
Use the Website for lawful business information, legitimate enquiries, authorised pharmaceutical distribution relationships and other purposes consistent with its published functions.
2. Prohibited use
- Attempting unauthorised access to the Website, hosting environment, email systems, databases, portals or accounts.
- Introducing malware, ransomware, malicious code, automated attacks or denial-of-service traffic.
- Scraping, harvesting or collecting personal data or contact details without lawful authority.
- Submitting false identities, fake licenses, forged prescriptions, fraudulent purchase orders or misleading business credentials.
- Using the Website to promote unlawful medicines, counterfeit products, diversion, unauthorized resale or any breach of pharmaceutical law.
- Uploading confidential patient information or sensitive health records into a general contact form.
- Infringing intellectual property, defaming others, harassing staff or distributing unlawful, abusive or deceptive material.
- Circumventing access controls, rate limits, security measures or cookie / consent choices.
3. Account and credential safety
If a Company-controlled service provides an account, keep credentials confidential, use strong passwords and notify the Company promptly of suspected compromise. You are responsible for activity performed through your account unless applicable law provides otherwise.
4. Monitoring and enforcement
The Company may monitor system logs and investigate suspected misuse to protect its systems, users, business partners and legal obligations. It may block access, preserve evidence, report unlawful activity to authorities or take legal action where appropriate.
5. Reporting misuse
Report suspected abuse, phishing, security weaknesses or unauthorized use to info@sklifetime.com. Do not publicly disclose a vulnerability before allowing a reasonable opportunity for investigation.